STOP T1D’s Post

eggs and role in diabetes-series1 One egg per day saves the patient from six or seven tablets. First is the egg along with white and yolk is very important and useful for both heart patients and diabetic patients, hypertensive, obese people. It, it has a acarbose tablet like effect wherein the It stops the carbohydrate from breaking down  INSULIN BLOOD TEST AND TRIGLYCERIES TO GLUCOSE INDEX BLOOD TESTS ONLY TELL US WHETHER WE ARE REALLY HEALHY THAN ALL THE [00:01:00] HUNDREDS OF TESTS DONE DURING ROUTINE CHECK UPS ARE MISSED. insulin test 1 single important test instead of hundreds of tests get HOMA AND TYG TEST 09963721999 

#Insulin adherence is critical for preventing diabetes-related complications, but rising OOP costs can create barriers to access. Insulin prices have drawn increasing attention from policymakers - but how effective are the resulting policies? Early evidence has shown that insulin copayment cap policies enacted among #Medicare Part D beneficiaries has increased the number of monthly prescription insulin fills. Though 25 states have adopted insulin OOP cap policies aimed at commercially insured populations since 2020, little is known about their effectiveness. A new study led by Harvard Pilgrim Health Care Institute's Laura Garabedian and Duke University researchers examined the effect of state insulin OOP caps on insulin use and OOP costs among commercially insured persons with diabetes. What they found: ▶ State policies intended to reduce insulin out-of-pocket (OOP) costs for commercially insured people were not associated with increased insulin use in the overall population. ▶ However, monthly insulin OOP costs declined substantially for members in high deductible health plans with health savings accounts, plans that generally require high insulin OOP payments. ▶ Despite cost savings seen among selected groups, the team found no increase in insulin use overall, and in most subgroups. 💻 Read the study online now in Annals of Internal Medicine: https://lnkd.in/gwTtzsJf

‘Starting Insulin Therapy in Primary Care’ https://lnkd.in/ejjjAF6B DON’T FORGET! Our next course starts on 20th March 2024 (09:30-15:30) 6 hours CPD Accredited! This is a virtual course for healthcare professionals in primary care that would like to increase their knowledge, confidence and competence in insulin initiation in people with type 2 diabetes in a primary care setting. The course is aimed: To understand the normal physiology of insulin and glucagon. To explore the pathophysiology of Type 2 Diabetes and potential progression to insulin therapy. To be able to identify which people would benefit from insulin therapy. To identify national and local guidelines and pivotal trials for the treatment of Type 2 Diabetes. To appreciate the importance of assessing psychological well-being. To understand the difference between Human, Analogue and Biosimilar Insulins. To understand the variety of insulins and their associated profiles. To discuss appropriate rationale for choosing an insulin type and regimen. To be aware of insulin safety. To bring theory to life through case studies. #diabetes #diabetesawareness #diabetesmanagement #diabeteseducation #insulin #primarycare #health #insulin #type2diabetes #pct #healthcare #cpd #nhs

It is estimated that 4.4 million people live with diabetes mellitus in the UK and this number is expected to rise. Around 90% of people with diabetes have type 2 diabetes mellitus, while 8% have type 1 diabetes mellitus, with rarer diabetes types accounting for the final 2%. The PJ is dedicated to continuing to inform and educate healthcare professionals to help improve the patient’s experience. Here is one example of a hub page on diabetes dedicated to just that. The hub page is designed to discuss and look into improving peoples lives who have to live with diabetes. The page focuses on the following. 1) Diagnosis and management. 2) Living with diabetes. 3) Research and future directions. 4) News and analysis. The pharmacy profession is undergoing rapid change as the role of the pharmacist evolves away from dispensing towards being medicines experts in a patient-facing role. Which is why the PJ team creates high-quality editorial content that reflects the everyday challenges faced by pharmacists across all sectors of practice and delivers professional and clinical resources to address their learning and development needs. Please get in touch for more information. #thepharmaceuticaljournal #PJ #hubpage #digital #diabetes #healthcare #research #news #pharma #advertising #digitaladvertising #medicines https://lnkd.in/eXaKp576

The Proof is in the pudding: Continuous Glucose Monitors are revolutionizing diabetes management for non-insulin dependent patients! According to recent insights shared by Kaczor, the uptick in non-insulin CGM users in 2023 surpassed expectations, with nearly 300,000 new adopters compared to the projected 200,000. This surge is a clear indication of the growing acceptance and efficacy of CGM technology among non-insulin dependent diabetes patients. With such compelling data on the rise of non-insulin CGM usage, it's hoped that Medicare will take note and consider revising guidelines to make qualification easier for non-insulin dependent individuals. By recognizing the benefits and accessibility of CGMs for this demographic, Medicare can further enhance diabetes care and support a broader spectrum of patients in managing their health effectively. https://lnkd.in/ebKmGYnp #Medicare #Diabetescare #CGM #Libre #Dexcom

Insulin Innovations and Global Health: Addressing Access and Affordability Insulin is a life-saving medication for millions of diabetics worldwide, but challenges in affordability and access remain significant. This post delves into the latest innovations in insulin therapy, such as smart insulin pens, continuous glucose monitors, and biosimilar insulins that promise improved diabetes management and cost efficiency. We also explore the global health implications of insulin pricing, highlighting the disparities in access and the efforts of advocacy groups to ensure affordability. Understanding these dynamics is crucial as we look towards future trends in insulin therapy, including oral insulin and ultra-rapid-acting formulations, which aim to simplify diabetes care and enhance patient outcomes. Join us in discussing the critical issues and advancements shaping the future of insulin and diabetes management. #Insulin #Diabetes #Healthcare #Innovation #GlobalHealth #AffordableMedicine #Biosimilars #MedicalAdvancements #HealthPolicy

#mediception glad to publish our #rwe article on "Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India", for our sponsor. The article talks about how initiation or switching to IDegAsp led to improvement in glycaemic control in Indian patients. #publication #diabetes #Insulin #Idegasp #clinicalstudies #pms

Despite the significant benefits of technology in supporting patients with diabetes to better manage their blood glucose and significantly reduce their risk of complications, technology remains unaffordable for many. Although all Australians with type 1 diabetes are eligible for subsidised continuous glucose monitor technology, the same cannot be said for insulin pump therapy. Only 24% of Australians living with type 1 are able to access this technology, which is lower than the US, where 63% of adults and 58% of children use an insulin pump to manage their type 1 diabetes. Link to report: https://lnkd.in/gg7rxJte It is promising to see expanded access to insulin pumps for people with type 1 diabetes tabled within the recommendations of the recent Parlimantary Inquiry.

The Global HbA1c Testing Market is projected to soar with a remarkable growth rate of 9-12% by 2028! 📈 As diabetes prevalence continues to rise worldwide, routine HbA1c testing plays a crucial role in effective diabetes management. Patients are increasingly recognizing the significance of regular testing, leading to a surge in demand for less-invasive and accurate testing methods. Some of the key players operating in the market are Abbott, Bio-Rad Laboratories, ARKRAY,Inc., Danaher Corporation, Roche, Siemens Healthineers, Transasia Bio-Medicals Ltd., Trinity Biotech, EKF Diagnostics, Beckman Coulter Diagnostics, and Randox among others. Unlock valuable market insights, request your sample report now https://lnkd.in/dBR-hGP8 Join us in the journey towards better diabetes management and improved healthcare outcomes! 💪 #HealthcareInnovation #DiabetesManagement #HbA1cTesting #GlobalHealthcare #HealthTech #MedicalInnovation #HealthcareIndustry #HealthcareTechnology #MedicalDevices #HealthAwareness #PatientCare #HealthEquity #HealthForAll #DigitalHealth #InnovationInHealthcare #HealthcareTrends #MedicalResearch #GlobalHealth #HealthcareProviders #PublicHealth #HealthyLiving #DiabetesAwareness #HealthAndWellness #HealthcareSolutions #HbA1c #GlycatedHemoglobin #DiabetesTesting #BloodSugarControl #A1cTest #DiabetesCare #GlucoseMonitoring #Endocrinology #DiabetesPrevention #BloodSugarLevels #Type1Diabetes #Type2Diabetes #InsulinResistance #MetabolicHealth #HealthyBloodSugar #ContinuousGlucoseMonitoring #HealthCheck #PreventiveCare

As diabetes prevalence continues to rise worldwide, routine HbA1c testing plays a crucial role in effective diabetes management. Patients are increasingly recognizing the significance of regular testing, leading to a surge in demand for less-invasive and accurate testing methods. Some of the key players operating in the market are Abbott, Bio-Rad Laboratories, ARKRAY,Inc., Danaher Corporation, Roche, Siemens Healthineers, Transasia Bio-Medicals Ltd., Trinity Biotech, EKF Diagnostics, Beckman Coulter Diagnostics, and Randox among others. Unlock valuable market insights, request your sample report now https://lnkd.in/dBR-hGP8 Join us in the journey towards better diabetes management and improved healthcare outcomes! 💪 #HealthcareInnovation #DiabetesManagement #HbA1cTesting #GlobalHealthcare #HealthTech #MedicalInnovation #HealthcareIndustry #HealthcareTechnology #MedicalDevices #HealthAwareness #PatientCare #HealthEquity #HealthForAll #DigitalHealth #InnovationInHealthcare #HealthcareTrends #MedicalResearch #GlobalHealth #HealthcareProviders #PublicHealth #HealthyLiving #DiabetesAwareness #HealthAndWellness #HealthcareSolutions #HbA1c #GlycatedHemoglobin #DiabetesTesting #BloodSugarControl #A1cTest #DiabetesCare #GlucoseMonitoring #Endocrinology #DiabetesPrevention #BloodSugarLevels #Type1Diabetes #Type2Diabetes #InsulinResistance #MetabolicHealth #HealthyBloodSugar #ContinuousGlucoseMonitoring #HealthCheck #PreventiveCare